Interview with Jim MacKrell, Associate Vice President & Head of East Coast (US) Venture Science – Lilly New Ventures, Eli Lilly and Company

10 Nov

By Caitlin Dolegowski, Marketing Specialist, LSN

Jim MacKrell, Associate Vice President & Head of East Coast (US) Venture Science – Lilly New Ventures, Eli Lilly and Company works to identify innovation in core therapeutic areas: diabetes, neuroscience, pain, oncology, and immunotherapy. Lilly New Ventures is expanding its presence in the Boston area and attended RESI Boston as a title sponsor with a goal of expanding relationships with local startups and investors. The diversity and quality of companies and the representation of the Boston life science ecosystem made RESI the right fit for them to “collide with innovators”. Learn more from Jim on Lilly’s focus on genetic medicine, the significance of a balance of persistence and patience that early-stage companies need to have and the importance of strong science.

RESI San Francisco, January 10, followed by two days of virtual, January 11 & 12 is next! Save $300 when you register by November 25 with early bird rates.

Register-now-button-new

RESI-SF-2023-Banner-1100px-11032022

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: